Glutamine in the ICU: Who needs supply?

Clinical Nutrition

Volumn 32, Issue 4, 2013, Pages 668-669

  Gottschalk, Antje ^a   Wempe, Carola ^a   Goeters, Christiane ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Glutamine; ICU; Multiple organ failure

Indexed keywords

GLUTAMINE;

AMINO ACID DEFICIENCY; CONTINUOUS HEMOFILTRATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; HEALTH CARE NEED; HEART RIGHT VENTRICLE FAILURE; HUMAN; INTENSIVE CARE UNIT; LETTER; MORTALITY; MULTIPLE ORGAN FAILURE; PREDICTION; PROTEIN DEPLETION; SENSITIVITY AND SPECIFICITY; SHOCK;

GLUTAMINE; HEART FAILURE; HUMANS; INTENSIVE CARE UNITS;

EID: 84879460402     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.12.004     Document Type: Letter

References (3)

1. Goeters C., Wenn A., Mertes N., Wempe C., Van Aken H., Stehle P., et al. Parenteral l-alanyl-l-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 2002, 30:2032-2037.
2. Rodas P.C., Rooyackers O., Hebert C., Norberg A., Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond) 2012, 122:591-597.
3. Goeters C., Mertes N., Kuhmann M., Lawin P. Substratverluste unter kontinuierlicher veno-venöser Filtration (CVVH). Akt Ernär Med 1994, 19:62.